Ivan Dimov (left) and Rick Klausner
A pair of Bay Area biotech upstarts with deep pockets and a shared interest in curative cancer drugs join R&D forces
Two Bay Area upstarts with close connections are joining forces today in the hunt for cell therapy 2.0. And the deal is bonding some brash …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
